Shijie Xu Selected Research

Wnt Proteins

1/2022	Altered Wnt5a expression affects radiosensitivity of non-small cell lung cancer via the Wnt/β-catenin pathway.
1/2020	Overexpression of Wnt7a enhances radiosensitivity of non-small-cell lung cancer via the Wnt/JNK pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shijie Xu Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 08/2014
8	Infections 09/2021 - 11/2015
4	Hyperalgesia 01/2018 - 08/2014
3	Pain (Aches) 01/2018 - 08/2014
3	Bone Neoplasms (Bone Cancer) 01/2017 - 08/2014
2	Glioma (Gliomas) 01/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
2	Inflammation (Inflammations) 09/2021 - 09/2020
2	Herpes Simplex 09/2021 - 11/2015
2	Stomach Neoplasms (Stomach Cancer) 10/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2016 - 08/2014
2	Rheumatoid Arthritis 02/2012 - 06/2011
1	COVID-19 10/2021
1	Human Influenza (Influenza) 10/2021
1	Colitis 09/2021
1	Lung Injury 09/2021
1	Cardiotoxicity 06/2021
1	Hemorrhage 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Papillomavirus Infections 01/2021
1	Lymphatic Metastasis 10/2020
1	Ebola Hemorrhagic Fever 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Meningioma (Meningiomas) 10/2019
1	Plague (Bubonic Plague) 07/2018
1	Substance-Related Disorders (Drug Abuse) 01/2017

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 09/2021 - 08/2014
5	VaccinesIBA 01/2021 - 07/2018
4	Pharmaceutical PreparationsIBA 09/2021 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 09/2021 - 07/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2016 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Wnt ProteinsIBA 01/2022 - 01/2020
2	LipopolysaccharidesIBA 09/2021 - 09/2020
2	Antiviral Agents (Antivirals)IBA 09/2021 - 07/2018
2	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2021 - 04/2019
2	Biological ProductsIBA 01/2021 - 01/2021
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 10/2020 - 10/2020
2	Harmine (Telepathine)IBA 07/2018 - 11/2015
2	2,2-dimethylpropionic acid 3- (2- chloro- 6- methylaminopurin- 9- yl)- 2- (2,2- dimethylpropionyloxymethyl)propyl esterIBA 01/2017 - 08/2014
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 08/2014
2	SolutionsIBA 01/2016 - 08/2014
1	CateninsIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Single-Domain AntibodiesIBA 10/2021
1	JNJ4796IBA 10/2021
1	Hemagglutinins (Hemagglutinin)IBA 10/2021
1	Polysaccharides (Glycans)IBA 09/2021
1	EnzymesIBA 09/2021
1	Dextrans (Dextran)FDA Link 09/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 09/2021
1	InflammasomesIBA 09/2021
1	Acyclovir (Aciclovir)FDA LinkGeneric 09/2021
1	NSC 23766IBA 09/2021
1	Ganciclovir (Cytovene)FDA LinkGeneric 09/2021
1	rac1 GTP-Binding ProteinIBA 09/2021
1	Antitubercular AgentsIBA 06/2021
1	APTIBA 01/2021
1	cadherin 5IBA 01/2021
1	AmidesIBA 01/2021
1	CurcuminIBA 01/2021
1	Protons (Proton)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	HydrogelsIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Long Noncoding RNAIBA 10/2020
1	alpha2 Subunit Collagen Type IIBA 10/2020
1	Competitive Endogenous RNAIBA 10/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2020
1	Dinoprostone (PGE2)FDA Link 09/2020
1	Immunomodulating AgentsIBA 01/2020
1	18 L1 type 16 human papillomavirus vaccine (Cervarix)IBA 04/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2018
1	Viral RNAIBA 07/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	CC ChemokinesIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	InterferonsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	ChemokinesIBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2017

Therapy/Procedure

6	Therapeutics 09/2021 - 06/2011
2	Immunotherapy 01/2021 - 01/2020
2	Spinal Injections 01/2016 - 08/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2012 - 06/2011
1	Intranasal Administration 10/2021
1	Oral Administration 10/2021
1	Chemoradiotherapy 01/2021
1	Adjuvant Radiotherapy 10/2019
1	Radiotherapy 10/2019
1	Drug Therapy (Chemotherapy) 01/2019